companydata.dkcompanydata.dk

Troya Therapeutics ApS: Financial statements 2025

CVR: 44032589

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Troya Therapeutics ApS (CVR 44032589) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,381,639 and a net result of DKK -4,638,321 compared with DKK -1,440,941 the year before. Equity in the 2025 report amounted to DKK -6,398,479. The company had 4 employees in the financial year.

Gross Profit
DKK -2,381,639
Profit/Loss
DKK -4,638,321
Equity
DKK -6,398,479
Total Assets
DKK 9,932,157
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--2.4M-4.6M-6.4M4
2024--991K-1.4M-1.8M0

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Troya Therapeutics ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Christian Grøndahl joins the board of Troya Therapeutics ApSDec 22, 2025

As of December 22, 2025, Christian Grøndahl has joined the board of directors of Troya Therapeutics ApS.

Jan Johannes Enghild leaves the board of Troya Therapeutics ApSDec 22, 2025

As of December 22, 2025, Jan Johannes Enghild has left the board of directors of Troya Therapeutics ApS.

Troya Therapeutics ApS: The 2024 annual report is outApr 24, 2025

Troya Therapeutics ApS has published its annual report for 2024. Gross profit came to DKK -991,416, and the net result was DKK -1,440,941.

Ulrik Bjerl Nielsen registered as owner of Troya Therapeutics ApSMar 7, 2025

As of March 7, 2025, Ulrik Bjerl Nielsen is registered as an owner of Troya Therapeutics ApS with an ownership share of 33%.

Registered as owner of Troya Therapeutics ApSMar 7, 2025

As of March 7, 2025, is registered as an owner of Troya Therapeutics ApS with an ownership share of 10%.

About Troya Therapeutics ApS

Troya Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Austin Wayne Boesch. The board consists of Ulrik Bjerl Nielsen (chair), Christian Grøndahl and Sean Dean Lykke Harwood. The company's owners include Ulrik Bjerl Nielsen, Seandean Lykke Harwood Holding ApS and EnghildThøgersen Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -2,381,639 and a net result of DKK -4,638,321 compared with DKK -1,440,941 the year before. Equity in the 2025 report amounted to DKK -6,398,479.

Source: annual report 2025, Danish Business Authority

Other financial years